Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.00 (0.00%)
Bid:
2.80
Ask:
3.20
Spread: 0.40 (14.286%)
Market Cap: £5.64m
SEED Live PriceLast checked at - London Stock Exchange

Intraday Seed Share Chart

Completion of share buy-back programme

5 Jun 2024 07:00

RNS Number : 1144R
Seed Innovations Limited
05 June 2024
 

 

5 June 2024

SEED Innovations Limited

("SEED" or the "Company")

 

Completion of Share Buy-Back Programme

 

Payment of maiden dividend of circa. £2 million and £0.51 million Buy-Back programme

 

SEED Innovations Ltd, the AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors, is pleased to announce completion of its Share Buy-Back Programme (the "Programme") announced via RNS on 19 September 2023 and extended on 29 February 2024. Since the commencement of the Programme, the Company has repurchased 19,797,500 shares for a total consideration of approximately £0.51 million, at an average price of 2.58p per share. This represented 9.31% of the issued share capital of the Company (excluding 2,472,446 treasury shares) when the Programme commenced.

 

Of the issued share capital of 215,219,841 ordinary shares, the Company now holds a total of 22,269,946 shares in treasury, with the remaining 192,949,895 shares representing the total voting rights in the Company which may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

The Programme has been conducted within the safe harbour parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019). Details of all purchases made pursuant to the Programme were announced via RNS and published on the Company's website as required by the Market Abuse Regulations.

 

Commenting on the Programme, SEED CEO Ed McDermott said: "The decision to buy-back some of our shares was made in light of the disparity between the Net Asset Value (NAV) and the share price. The result of the share Buy-Back is over £0.5 million worth of shares bought back and another £2 million returned to Shareholders by way of the 1p special dividend, utilising over £2.5 million in total. It is now time to focus on our existing portfolio and further adding new investments. We believe these will deliver the returns which will allow us to reduce further the shares in issue and deliver further dividends in the future."

 

-Ends-

 

 

For further information on the Company please visit: www.seedinnovations.co or contact: 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co 

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Ana Ribeiro/ Isabel de Salis /Isabelle Morris

 

St Brides Partners Ltd,

Financial PR

E: seed@stbridespartners.co.uk

 

Notes

Seed Innovations Ltd

SEED Innovations Ltd is an AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors. Its strategy focuses on identifying early-stage opportunities with upcoming investment catalysts, alongside more mature investments providing near-term liquidity. With a portfolio of such investments and cash reserves, the company is agile and poised to capitalise swiftly on new investment opportunities. 

 

Nominated Adviser

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPUMPQUPCGQC
Date   Source Headline
21st Mar 202410:25 amRNSTransaction in Own Shares & TVR
21st Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20242:30 pmRNSInvestee Company Update: Northern Leaf
13th Mar 202412:23 pmRNSTransaction in Own Shares & TVR
12th Mar 202412:19 pmRNSTransaction in Own Shares & TVR
11th Mar 202411:27 amRNSTransaction in Own Shares & TVR
7th Mar 20241:09 pmRNSTransaction in Own Shares
7th Mar 20249:08 amRNSTransaction in Own Shares & TVR
29th Feb 20249:00 amRNSContinuation of Existing Share Buy-Back Programme
20th Feb 20244:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
19th Feb 20247:00 amRNSTransaction in Own Shares & TVR
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares & TVR
8th Feb 20247:00 amRNSTransaction in Own Shares & TVR
7th Feb 20247:00 amRNSTransaction in Own Shares & TVR
5th Feb 20242:00 pmRNSTransaction in Own Shares & TVR
1st Feb 20243:22 pmRNSTransaction in Own Shares & TVR
1st Feb 202410:06 amRNSInvestee Company Update: Little Green Pharma Ltd
26th Jan 20247:00 amRNSTransaction in Own Shares & TVR
25th Jan 20243:03 pmRNSInvestee Company Update: Avextra AG Raises €3.3m
25th Jan 20247:00 amRNSTransaction in Own Shares & TVR
24th Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSTransaction in Own Shares & TVR
22nd Jan 20247:00 amRNSCEO Presenting at Proactive One2One Investor Forum
19th Jan 20246:23 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTransaction in Own Shares & TVR
28th Dec 20237:00 amRNSTransaction in Own Shares & TVR
22nd Dec 202311:10 amRNSInvestee Company Updates
19th Dec 20237:00 amRNSTransaction in Own Shares & TVR
18th Dec 20237:00 amRNSTransaction in Own Shares & TVR
13th Dec 20237:00 amRNSTransaction in Own Shares & TVR
12th Dec 20237:00 amRNSTransaction in Own Shares & TVR
11th Dec 20237:00 amRNSTransaction in Own Shares & TVR
8th Dec 20237:00 amRNSTransaction in Own Shares & TVR
7th Dec 20234:52 pmRNSInvestee Company Update: Little Green Pharma Ltd
7th Dec 20237:00 amRNSTransaction in Own Shares & TVR
5th Dec 20239:20 amRNSInvestee Company Update: Clean Food Group
5th Dec 20237:00 amRNSTransaction in Own Shares & TVR
4th Dec 20238:44 amRNSTransaction in Own Shares & TVR
30th Nov 202312:44 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th Nov 20237:00 amRNSTransaction in Own Shares and TVR
29th Nov 20237:00 amRNSTransaction in Own Shares & TVR
28th Nov 202312:51 pmRNSInvestee Company Update: Clean Food Group
28th Nov 20239:00 amRNSTransaction in Own Shares & TVR
24th Nov 20237:00 amRNSTransaction in Own Shares & TVR
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20232:29 pmRNSInterim Results
20th Nov 202310:18 amRNSInvestee Company Update: Little Green Pharma Ltd
20th Nov 20237:00 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.